Teladoc Health, Inc. (BMV:TDOC)

Teladoc Health Statistics

Total Valuation

Teladoc Health has a market cap or net worth of MXN 24.84 billion. The enterprise value is 31.49 billion.

Market Cap	24.84B
Enterprise Value	31.49B

Important Dates

The last earnings date was Friday, July 25, 2025.

Earnings Date	Jul 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	176.69M
Shares Outstanding	n/a
Shares Change (YoY)	+3.77%
Shares Change (QoQ)	+1.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	174.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.52
PB Ratio	0.93
P/TBV Ratio	n/a
P/FCF Ratio	4.52
P/OCF Ratio	4.34
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 54.26, with an EV/FCF ratio of 5.72.

EV / Earnings	-8.05
EV / Sales	0.66
EV / EBITDA	54.26
EV / EBIT	n/a
EV / FCF	5.72

Financial Position

The company has a current ratio of 2.67, with a Debt / Equity ratio of 0.73.

Current Ratio	2.67
Quick Ratio	2.27
Debt / Equity	0.73
Debt / EBITDA	33.35
Debt / FCF	3.55
Interest Coverage	-8.07

Financial Efficiency

Return on equity (ROE) is -14.18% and return on invested capital (ROIC) is -4.13%.

Return on Equity (ROE)	-14.18%
Return on Assets (ROA)	-3.57%
Return on Invested Capital (ROIC)	-4.13%
Return on Capital Employed (ROCE)	-7.36%
Revenue Per Employee	9.47M
Profits Per Employee	-772,802
Employee Count	5,500
Asset Turnover	0.79
Inventory Turnover	20.70

Taxes

Income Tax	-471.46M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.03% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+7.03%
50-Day Moving Average	145.02
200-Day Moving Average	175.93
Relative Strength Index (RSI)	47.40
Average Volume (20 Days)	1,012

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.37

Income Statement

In the last 12 months, Teladoc Health had revenue of MXN 47.94 billion and -3.91 billion in losses. Loss per share was -22.53.

Revenue	47.94B
Gross Profit	33.69B
Operating Income	-3.46B
Pretax Income	-4.38B
Net Income	-3.91B
EBITDA	356.08M
EBIT	-3.46B
Loss Per Share	-22.53

Balance Sheet

The company has 12.82 billion in cash and 19.52 billion in debt, giving a net cash position of -6.70 billion.

Cash & Cash Equivalents	12.82B
Total Debt	19.52B
Net Cash	-6.70B
Net Cash Per Share	n/a
Equity (Book Value)	26.82B
Book Value Per Share	151.86
Working Capital	12.66B

Cash Flow

In the last 12 months, operating cash flow was 5.72 billion and capital expenditures -221.07 million, giving a free cash flow of 5.50 billion.

Operating Cash Flow	5.72B
Capital Expenditures	-221.07M
Free Cash Flow	5.50B
FCF Per Share	n/a

Margins

Gross margin is 70.26%, with operating and profit margins of -7.22% and -8.16%.

Gross Margin	70.26%
Operating Margin	-7.22%
Pretax Margin	-9.14%
Profit Margin	-8.16%
EBITDA Margin	0.74%
EBIT Margin	-7.22%
FCF Margin	11.47%

Dividends & Yields

Teladoc Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.77%
Shareholder Yield	n/a
Earnings Yield	-15.74%
FCF Yield	22.14%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Teladoc Health has an Altman Z-Score of -6.34 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.34
Piotroski F-Score	4